chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On April  10, 2021 I began to get "charlie horse" type cramps.  The pain began in my toes then quickly moved into both calves and became excruciating.  The calf muscle turned rock hard and felt as if it were pulling all my muscles upward.  The pain continued up both legs, simultaneous and individually, into my growing.  This pain felt like sharp knives and lasted for 2 hours before subsiding.  Today  my calf muscles are extremely sore and sensitive to touch.  The muscles are still so tense they feel like rocks.
Pt  was  administered Pfizer covid vaccination  after 2 minutes  of administering the  vaccination   i have noticed that pt is  losing her balance pt was  siting  ina chair  near the observation table  ; pt was  conscious , but  feeling really dizzy  and tried   pt came back to  normal in few  minutes ; called 911 ems came and checked on the pt on the vital were normal  and  pt mother refused  to go to hospital
Felt like she was gonna faint/Lil dizzy; My vision started getting dark; Sweating; Getting hot; Hearing is muffled/ kinda fuzzy; hot and cold; Headache; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 23 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 26Oct2021 (Lot number: FF2593) at the age of 23 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Lot: FE3592, ), administration date: 05Oct2021, when the patient was 23 years old, for COVID-19 Immunization. The following information was reported: FEELING HOT (non-serious) with onset 27Oct2021, outcome "unknown", described as "Getting hot"; HYPOACUSIS (non-serious) with onset 27Oct2021, outcome "unknown", described as "Hearing is muffled/ kinda fuzzy"; FEELING OF BODY TEMPERATURE CHANGE (non-serious) with onset Oct2021, outcome "unknown", described as "hot and cold"; DIZZINESS (non-serious) with onset 27Oct2021, outcome "unknown", described as "Felt like she was gonna faint/Lil dizzy"; VISUAL IMPAIRMENT (non-serious) with onset 27Oct2021, outcome "unknown", described as "My vision started getting dark"; HYPERHIDROSIS (non-serious) with onset 27Oct2021, outcome "unknown", described as "Sweating"; HEADACHE (non-serious) with onset Oct2021, outcome "unknown", described as "Headache"; FATIGUE (non-serious) with onset Oct2021, outcome "unknown", described as "tired".  Additional information: Caller said she was standing up for a while then all of a sudden, she started getting hot and started sweating for 15 minutes when the room is not even hot. Then all of a sudden, caller felt a lil dizzy and her vision in which her eyes were opened but felt like closing and started getting dark, almost all the way black. Caller added that her hearing is muffled when other people are talking it sounded kinda fuzzy. It sounded weird when other people were talking and I felt like I was going to faint but I have never fainted before and felt like I was going to faint.  No follow-up attempts are possible. No further information is expected.
12 hours after receiving the second shot I experienced all over body aches,  99.7 fever, chills, headache, nausea, fatigue. These symptoms  lasted about 12 hours until the following day when I took ibuprofen and  a hot  bath. This relieved the body aches. Alka seltzer relieved the nausea. The headache lasted for a full 3 days despite continuing to take ibuprofen.
Red raised welt appeared at injection one week after. The spot was warm. The right arm hurt from the injection down into the hand and fingers. This didn?t appear until after one week.
chicken pox like bumps to body. very sore, then fluid comes out from the bump, then scabs over. Still has this. Tachycardia and  shortness of breath, dizzy. Dermatologist did a biopsy and said it came back as inflammation on biopsy. Cardiologist said, it was most likely from inflammation to heart post covid.  Still having symptoms.  Am I allergic to this? Is it because I have an autoimmune disease.?
Within about 5 minutes after the injection, I experienced the following symptoms, in this order: 1) Light headedness 2) Increase heart rate 3) Hands tingling 4) Upper Lip numbness
Two days after vaccination I began experiencing symptoms of a cold (runny nose, sneezing, sore throat and cough).  I tested for Covid and the result was negative 3 days after the symptoms began.
I was diagnosed with gestational diabetes. (May be totally unrelated to the vaccine of course, just wanted to mention.) My estimated date of delivery is 10/13. I already had a few risk factors for gestational diabetes (PCOS, over 35).
Information has been received from a registered nurse referring to 2 patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 01-SEP-2015, the patients were vaccinated with ZOSTAVAX (0.65 ml, Lot #L016284, expiration date: 07-AUG-2016), which were improperly stored for 19 days. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
PAIN AT INJECTION SITE THAT PERSISTED FOR A FEW WEEKS AND PROGRESSED TO PAIN AND HEAVINESS SENSATION IN THE DELTOID AND SUPRASPINOUS AREA.  THIS SENSATION HAS PERSISTED AND IS UNCOMFORTABLE ENOUGH HE CANNOT SLEEP ON LEFT SIDE.  OF NOTE, HE WAS IN A MVA WITH ROLL-OVER THE DAY BEFORE HIS 2ND MODERNA VACCINATION.  HE WAS TREATED FOR WHIPLASH INJURIES AT THE TIME.    NO PRIOR SURGERIES OF INJECTIONS TO THE LEFT SHOULDER.
Patient had seizure at 6:30 am the next morning after having the flu shot. Went to ER. Precautionary.
11pm 4/12/21 ringing in right ear.  10am 4/12/21 continuous same ringing in right ear.   I have no previous experience with tinnitus. Ringing does not go away.
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. On 13-APR-2015, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (lot number, dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
The spouse reported onset of symptoms on 5/20/21 including lethargy.  He reported that on 5/27/21, her speech became slurred and she died.  Per spouse, an autopsy is pending.
Throbbing glands on both sides of neck and sublingual, causing tightness in throat  and difficulty swallowing  beginning about 5 days after injection, continuing into present (10 days after injection)
After my last dose of Gardasil in March i started with seizures in July 2013 i do not have a family history of seizure disorder. I had 3 full blown seizures had to go to Hospital get an IV in me and rest. Now on Keppra 1000mg's still.
Rash started 2-3 days after MMR shot and lasted 3 days, no other problems.
Patient recieved 0.5 IM Rabies in right deltoid at approximately 12:30 PM.  In less than 1 hr after vaccination, pt noticed he had odd taste in mouth.  Pt reported to work.  Pt noted he felt cold/shaky.  At 5pm, pt was sweating, cold, shaky.  At 6pm, pt noted his lips were pale.  At 6:45pm, pt reported to the ER.  Poison control spoke with patient in person.  I spoke with patient today on the phone and he reported he is feeling fine.
Mild to moderate soreness at vaccination site for around 48 hours; This is a spontaneous report from a contactable physician, the patient. A 63-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Mar2021 at 11:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021, the patient experienced mild to moderate soreness at vaccination site for around 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild to moderate soreness at vaccination site was recovered on 05Mar2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
p/being put to bed @ 7PM day of immun pt was restless, wakened briefly several times; 1AM woke up again & cried for several hrs; cry seemed nl temp between 102-103; APAP given during noc; contacted MD;
Information has been received from a health professional concerning 2, 15 month old pts, who on 4/3/01 were vaccinated with MMRII (lot 639491/0600L). The RN reported that shortly after the vaccination, the pts experienced a fever of 104F. Additional information has been requested.
Fever and Chills began 9 hours after receiving vaccine. Continued for 18 hours.  Fatigue 24 hours
This case was reported by a healthcare professional and described the occurrence of eczema in an infant subject of unspecified gender who was vaccinated with HAVRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of HAVRIX (unknown). At an unspecified time after vaccination with HAVRIX, the subject experienced eczema and hair loss. At the time of reporting the outcome of the eczema and hair loss was unspecified. At the time of the report no other information was provided.
Tiredness starting at 2pm Headache starting at 7pm Chills, body aches,headache, fatigue  staring at 4:00am through 10pm 4/2. 4/3 7am headache and lymph node right arm pit swollen and sore
Patient was given pediarix instead of daptacel at time of visit. Pt has had no reaction to vaccine.
Tachycardia, persisting for 4 days, rates up to 160 bpm, abnormal ekg : sinus tach with flipped T waves in inferior leads suggesting ischemia.
The patient experienced no symptoms.; a patient was administered an improperly stored dose of VARIVAX on 12/12/2019; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.    On 12-DEC-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot #: R030611, expiration date: 23-OCT-2020; strength, frequency and dose details were unknown) subcutaneously for prophylaxis (product storage error). The sterile diluent used for administration was properly stored.  The vaccine was stored at -13.3 degrees Celsius for 29 minutes. There were no previous temperature excursions. The digital data logger was involved. The patient experienced no symptoms.
This is a spontaneous report from a non-contactable consumer (patient's parent). A male patient of an unspecified age and ethnicity received two doses of TRUMENBA, via unspecified route of administration, on unspecified dates, at unspecified doses. The patient's medical history and concomitant medications were not reported. The patient's parent mentioned that he received these 2 doses on time. As the patient had an illness he could not receive the third dose, he was a month late now. No follow-up attempts possible. No further information expected.
8hr pos vax pt exp swelling in arm, soreness @ inj site, redness size of tennis ball--sore throat-closing of throat-temp over 100 congestion, fever, aches, pain all over;
amnesia Narrative: What were the symptoms? (DETAILED): "I just got amnesia & becam very confused til about 8pm, when I started remembering things, some of the things. I think I recovered from the amnesia, I know what's going on now, definitely."
Circular red rash that appeared at injection site approximately 2 weeks after vaccination. Rash lasted for 3-4 days before fading away.
This case was reported by a pharmacist and described the occurrence of urine in dark yellow/orange in a 44-year-old male subject who was vaccinated with TWINRIX, (GlaxoSmithKline).  There was no relevant medical history.  The reporting pharmacist was not aware of any adverse events following previous vaccinations.  It was not known whether the subject was taking concomitant medications.  Concurrent vaccination included poliomyelitis vaccine inactivated (non-gsk); Sanofi Pasteur MSD given on 9 June 2009; typhoid vaccine (non-gsk); Sanofi Pasteur MSD given on 9 June 2009.  On 9 June 2009 at 09:30 the subject received 1st dose of TWINRIX (1 ml, unknown route, right arm).  Seven to ten days (the exact date was unknown) after vaccination with TWINRIX, the subject experienced dark yellow to orange color urine.  The event resolved after 10 days.  The pharmacist considered the event was possibly related to vaccination with TWINRIX.
it was rpt fr RN concerning pt who was vax & subsequently exp a lack of seroconversion
This case was reported by a other health professional via call center representative and described the occurrence of erythema of extremities in a 90-year-old female patient who received SHINGRIX (batch number TP5E5, expiry date 5th November 2020) for prophylaxis. On 9th July 2018, the patient received SHINGRIX (intramuscular). On 10th July 2018, 1 days after receiving SHINGRIX, the patient experienced erythema of extremities and skin irritation. On 12th July 2018, the patient experienced swelling arm. On an unknown date, the outcome of the erythema of extremities, skin irritation and swelling arm were not recovered/not resolved. It was unknown if the reporter considered the erythema of extremities, skin irritation and swelling arm to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on the left arm. The healthcare professional (HCP) reported that, the patient had redness and irritation on her arm. The next day, the redness became bigger to about 2 inches, and then the day after that, the redness was 3 to 4 inches in diameter and had swelling.
Case number PHEH2015US019860, is an initial spontaneous report received from a pharmacist on 02 Oct 2015. This report refers to a 47 year old female patient. Historical conditions and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514801) intramuscularly at a dose of 0.5 ml on 02 Oct 2015. The pharmacist reported that the vaccine FLUVIRIN that had reached 52 degree for 30 minutes was administered to the patient. No adverse event was reported following the medication error.
Morning of 3/25/21 noticed a large lump that was red, itchy, warm, and painful to touch at site of injection.
I experienced chest pain and palpitations two weeks after receiving the Covid Booster on March 5th. I was found to have Aftrial Flutter and had to be Electrically Cardioverted.  A second event happened on March 18th when I experienced chest pain and palpitations again and had to be brought into the ED via ambulance. I was found to have atrial flutter and also went into Supraventricular Tachycardia with a heart rate of 240 beats/min became dizzy and had a blood pressure of 74/55. I had to be chemically cardioverted with Adenosine .
Arm became red, itchy, painful, hot and hard to the touch (red form shoulder to elbow and almost all the way around the arm) at 9pm. Less painful/easier to move on day 2.
I started having pain in my body which was aching in the joints and muscles from the first dose which never went away. I also had abdominal pain. After the second dose I did not really get worse. The first dose made my body flare up which stayed after the second dose. I went to a lot of doctors trying to find out what was going on. I had CT scans and MRI scans done to find out what was causing my abdominal pain. On 01/05/2021 I had an appointment Dr. a gynecologist, they send me for testing. On 01/07/2021 the ultrasound at Hospital.  On 01/08/2021 I saw Dr. my PCP.  On 01/18/2021 I saw an orthopedic doctor about my problems with my back and joints. On 01/19/2021 I had a diagnostic x-ray (CT Scan).  On the 26th I went to Dr. my PCP. On 02/05/2021 I went to the Health ER, complaining of hurting and pain. They did an x-ray, and CT scan. On 02/23/2021, I had CT of the lumbar spine without IV contrast, that was done at the Imagining Center.  On 03/01/2021 I saw my PCP again. On May 18th I went to a Dr. a urologist to find out the pain. On March 23rd, Orth spine doctor.  April 5th Ortho, they did an MRI. On April 27th, I went to see her at Ortho. I saw her to discuss MRI results.  On May 13th I had a visit with Dr. a Gastroenterologist. Another visit on June 4th to Dr. On June 8th at the Baptist Health Imagining Center, I had a CT with contrast. On June 15th, I saw Dr. about the abdominal pain. On June 21st, I had Upper GI procedure at Hospital. I had one more MRI of my abdominal area in the week of the 14th of June at Imagining Center. They were doing that to see if there was anything preventing me of having surgery on my back. I had surgery on my back on the 24th of June. All the pain started after I had the first dose.
Irritable, wasn't sleeping well & carried fever of 101-102 w/a cough & runny nose x 10 days p/vax; MD advised cont non-aspirin pain reliever; rx'd cough med & felt may be related to DTP;
abrasions to my chest and left leg.; swelling; dramatically decreasedsensitivity to pain.; after receiving the vaccine Ifell; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 12:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were reported as no. The patient had no known allergies. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 08:00, the patient experienced decreased sensitivity to pain, abrasions to chest, fall and left leg swelling. The patient reported that he experienced dramatically decreased sensitivity to pain and while jogging on morning after receiving the vaccine he fell and suffered abrasions on his chest and left leg. Despite clearly visible abrasions and swelling he experienced no pain at all. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event fall, swelling, abrasions to chest and left leg and decreased sensitivity to pain were unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a Medical assistant refers to an unknown number of patients of unknown age and gender. The reporter mentioned that an unknown number of patients have received VARIVAX (Merck) (lot number and expiry date not reported) (dosing regimen and frequency unknown) from January 2013 to 16-DEC-2013 that may had an unknown number of excursions with temperatures from 3 degrees C to 7 degrees C and each excursion being 64 hours. No adverse effects reported. No product quality issue was reported. Follow-up information has been received from a medical assistant (who called to report specific administration dates), concerning a patient of unknown age and gender. On 04-MAR-2013 the patient had received a dose of VARIVAX (Merck) (lot number # H011233, exp. date: 06-JUN-2014) (dosing regimen and frequency were not provided). This dose of VARIVAX (Merck) had an unknown number of excursions with temperatures from minus 3 Celsius degree to minus 7 Celsius degree and each excursions being 64 hours. No adverse experiences were reported. This is one of 9 reports from the same source (# 1312USA008561; #1312USA011525; #1312USA011520; #1312USA011521; #1312USA011522; #1312USA011523; #1312USA011524; #1312USA011526). Additional information has been requested.
Vaccines administered while child sitting in a chair. Several minutes after receiving the vaccine, he stood up suddenly, then fainted. He was lifted to a chair and awake in seconds. He told his mother that the last shot (MENVEO) made him dizzy. He had told the nurse several minutes before he stood up that he was fine. The precise time that he received the vaccine and the precise number of minutes before he fainted is not known.
Moderna Covid 19 Vaccine EUA- First signs after getting the injection on Friday were injection site soreness and a softball size redness around the site.  Later that evening, this was followed by fever and chills, headache, nausea, severe muscle aches and pains,  and dizziness and weakness.  The fever and nausea were gone after about 36 hours.  Then after about 48 hours, I began to have a gradual diminishment of head and body aches and, fatigue.  Since it was the weekend, I could not reach my regular doctor or clinic and I assumed that the symptoms would get better and by Monday, I was generally just fatigued.  I did not take any of my own meds or pain relievers as I was unsure how they might affect the vaccine.
MENEVEO lyophilized portion inadvertently mixed with sterile water from another vaccine and given to patient. Vaccine was repeated wrong both components.
Pain in the site of injection lasting 2 days; This is a spontaneous report from a non-contactable consumer reported for herself. A 50-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL8982, via an unspecified route of administration on 22Jan2021 at single dose in right arm for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced pain in the site of injection lasting 2 days on 23Jan2021. The patient had not been tested for COVID-19 since the vaccination. No treatment was received for the event. The outcome of the event was recovered on 25Jan2021. Serious criteria was reported as non-serious.  No follow-up attempts are possible. No further information is expected.
This is a spontaneous report received from noncontactable consumer or other non-HCP. A male patient received the 3rd dose (first booster) of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. Vaccination history included the COVID-19 vaccine (primary immunization series complete; manufacturer unknown), for immunization. The patient had fatigue and pyrexia, with outcome of unknown. Pediatric male patient experienced fever and fatigue from COVID-19 vaccine booster. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
eye pain; This is a spontaneous report received from a contactable reporter (other HCP), Program ID. The reporter is the patient. A 35-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 VACCINE), on 17Dec2020 as dose 1, single (lot number EK5730) at the age of 35 years intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: EYE PAIN (non-serious), outcome "unknown".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200014413 same patient/product, different vaccine dose/event;